What is the personal cost of entrectinib after medical insurance?

Entrectinib, as a targeted therapy drug for specific types of cancer, has received widespread attention since its introduction. It has significant efficacy in patients with NTRK gene fusion and ROS1-positive non-small cell lung cancer, bringing new treatment hope to many patients. However, the high cost of drugs has always been a focus of concern for patients and their families. Fortunately, entrectinib has been included in the medical insurance catalog, reducing the financial burden for patients.

The post-Medicare individual cost of entrectinib varies by region, health insurance policy, and individual circumstances. Generally speaking, medical insurance will reimburse a certain percentage of drug costs, and patients need to pay the remaining portion as personal expenses. The specific reimbursement ratio and out-of-pocket amount depend on the medical insurance policy and insurance plan in the patient's region.

Taking some regions as an example, the medical insurance reimbursement ratio for entrectinib may reach60% to 70%. This means that if a patient purchases a monthly dose of entrectinib, the original price may be as high as tens of thousands of yuan, but after reimbursement by medical insurance, the actual cost that the patient needs to pay will be significantly reduced. The specific amount needs to be determined based on the patient's medical insurance situation and the specific policies of the region.

In addition to medical insurance reimbursement, some regions also provide auxiliary medical insurance policies, such as medical assistance plans, charitable assistance, etc., to further reduce the financial burden of patients. Patients can consult the local medical insurance department or relevant institutions for specific policies and application procedures.

In addition, the Lao market also provides some cheap versions of generic drugs at more affordable prices. This relieves a lot of burden on patients who cannot enjoy reimbursement benefits. For example, the size of each box of the Laos-ASEAN version is 200mg*90 tablets, and the price is about 6,000 to 7,000. There is also a version produced by the Second Pharmaceutical Factory in Laos, which is slightly more expensive. Each box is 100mg*60 pills and costs about 8,000.

In general, the personal cost of entrectinib after medical insurance varies by region and policy, but it has dropped significantly compared with the original price. Patients and family members should take the initiative to understand local medical insurance policies and reimbursement procedures in order to make better use of medical insurance resources and reduce financial burdens. At the same time, the emergence of overseas generic drugs has allowed more patients to benefit from entrectinib treatment.